Jeffrey L. Wade
2011
In 2011, Jeffrey L. Wade earned a total compensation of $1.1M as Executive Vice President, Corporate Development and Chief Financial Officer at Lexicon Pharmaceuticals, a 6% decrease compared to previous year.
Compensation breakdown
| Bonus | $105,000 |
|---|---|
| Option Awards | $415,770 |
| Salary | $385,000 |
| Stock Awards | $170,750 |
| Other | $6,679 |
| Total | $1,083,199 |
Wade received $415.8K in option awards, accounting for 38% of the total pay in 2011.
Wade also received $105K in bonus, $385K in salary, $170.8K in stock awards and $6.7K in other compensation.
Rankings
In 2011, Jeffrey L. Wade's compensation ranked 5,372nd out of 10,747 executives tracked by ExecPay. In other words, Wade earned more than 50.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,372 out of 10,747 | 50th |
Division Manufacturing | 1,950 out of 3,960 | 51st |
Major group Chemicals And Allied Products | 424 out of 1,033 | 59th |
Industry group Drugs | 265 out of 781 | 66th |
Industry Pharmaceutical Preparations | 206 out of 571 | 64th |
Source: SEC filing on March 14, 2014.
Wade's colleagues
We found four more compensation records of executives who worked with Jeffrey L. Wade at Lexicon Pharmaceuticals in 2011.
2011
Arthur Sands
Lexicon Pharmaceuticals
Chief Executive Officer
2011
Brian Zambrowicz
Lexicon Pharmaceuticals
Chief Scientific Officer
2011
Alan Main
Lexicon Pharmaceuticals
Executive Vice President of Pharmaceutical Research
2011
Pablo Lapuerta
Lexicon Pharmaceuticals
Chief Medical Officer
News
Lexicon Pharmaceuticals CEO Lonnel Coats' 2023 pay slips 1% to $4.1M
March 26, 2024
Lexicon Pharmaceuticals CEO Lonnel Coats' 2021 pay rises 2% to $3.9M
April 8, 2022
Lexicon Pharmaceuticals CEO Lonnel Coats' 2020 pay stays at $3.9M
March 19, 2021
Lexicon Pharmaceuticals CEO Lonnel Coats' 2019 pay jumps 24% to $3.9M
March 13, 2020
Lexicon Pharmaceuticals CEO Lonnel Coats' 2018 pay jumps 41% to $3.1M
March 14, 2019